Chen Y, Zhang D, Li J, Sun Y, Wang J, Xi L
Oncol Lett. 2025; 29(4):202.
PMID: 40070781
PMC: 11894506.
DOI: 10.3892/ol.2025.14948.
Wang W, Li T, Wu K
Cell Death Discov. 2025; 11(1):93.
PMID: 40064873
PMC: 11894105.
DOI: 10.1038/s41420-025-02376-1.
Hu Y, Qi E, Yun C, Li X, Liu F, Cheng Z
J Transl Med. 2025; 23(1):271.
PMID: 40038726
PMC: 11877846.
DOI: 10.1186/s12967-025-06247-2.
Wu J, Ding C, Zhang C, Xu Z, Deng Z, Wei H
Nat Commun. 2025; 16(1):2184.
PMID: 40038267
PMC: 11880502.
DOI: 10.1038/s41467-025-57511-4.
Nair A, Ghosh S, Babu V, Praveen M, Xin Y, Sahu G
bioRxiv. 2025; .
PMID: 39975064
PMC: 11838234.
DOI: 10.1101/2025.01.22.634301.
Pyroptosis: A Novel Therapeutic Target for Bioactive Compounds in Human Disease Treatment? A Narrative Review.
Yang B, Qi Z, Armas Diaz Y, Cassotta M, Grosso G, Cianciosi D
Nutrients. 2025; 17(3).
PMID: 39940319
PMC: 11820709.
DOI: 10.3390/nu17030461.
FOXP3 as a prognostic marker and therapeutic target in immunogenic cell death modulation for clear cell renal cell carcinoma.
Chen J, Zhu C, He Y, Huang L, Wang W, Huang S
Discov Oncol. 2025; 16(1):102.
PMID: 39883234
PMC: 11782763.
DOI: 10.1007/s12672-025-01831-w.
pir-hsa-216911 inhibit pyroptosis in hepatocellular carcinoma by suppressing TLR4 initiated GSDMD activation.
Liao Z, Yang L, Cheng X, Huang X, Zhang Q, Wen D
Cell Death Discov. 2025; 11(1):11.
PMID: 39824843
PMC: 11742400.
DOI: 10.1038/s41420-024-02285-9.
Comprehensive analyses reveal the promising value of gasdermins as prognostic biomarkers and immunotherapeutic targets in head and neck squamous cell carcinoma.
Huang H, Ge J, Lu S, Deng X, Tian Y, Huang H
Heliyon. 2025; 11(1):e41213.
PMID: 39807507
PMC: 11728984.
DOI: 10.1016/j.heliyon.2024.e41213.
IGF2BP2 Regulates the Progression of Alzheimer's Disease Through m6A-Mediated NLRP3 Inflammasome.
Jingrui W, Haihui Y, Jinjin Y, LE F
Immun Inflamm Dis. 2025; 13(1):e70121.
PMID: 39783247
PMC: 11713527.
DOI: 10.1002/iid3.70121.
Multi‑omics identification of a novel signature for serous ovarian carcinoma in the context of 3P medicine and based on twelve programmed cell death patterns: a multi-cohort machine learning study.
Ye L, Long C, Xu B, Yao X, Yu J, Luo Y
Mol Med. 2025; 31(1):5.
PMID: 39773329
PMC: 11707953.
DOI: 10.1186/s10020-024-01036-x.
Cytokine-armed pyroptosis induces antitumor immunity against diverse types of tumors.
Orehek S, Ramuta T, Lainscek D, Malensek S, Sala M, Bencina M
Nat Commun. 2024; 15(1):10801.
PMID: 39737979
PMC: 11686184.
DOI: 10.1038/s41467-024-55083-3.
Application of autophagy in mesenchymal stem cells.
Chai M, Zhang C, Chen S, Xu D
World J Stem Cells. 2024; 16(12):990-1001.
PMID: 39734481
PMC: 11669988.
DOI: 10.4252/wjsc.v16.i12.990.
Identification of pyroptosis-associated miRNAs in the immunoscape and prognosis of hepatocellular carcinoma.
Zheng Y, Huang X
BMC Cancer. 2024; 24(1):1513.
PMID: 39695414
PMC: 11657507.
DOI: 10.1186/s12885-024-13276-5.
Biological and pharmacological roles of pyroptosis in pulmonary inflammation and fibrosis: recent advances and future directions.
Liu Y, Wang D, Liu X, Yuan H, Liu D, Hu Y
Cell Commun Signal. 2024; 22(1):586.
PMID: 39639365
PMC: 11619304.
DOI: 10.1186/s12964-024-01966-3.
Crosstalk of pyroptosis and cytokine in the tumor microenvironment: from mechanisms to clinical implication.
Wang H, Wang T, Yan S, Tang J, Zhang Y, Wang L
Mol Cancer. 2024; 23(1):268.
PMID: 39614288
PMC: 11607834.
DOI: 10.1186/s12943-024-02183-9.
The Role of Pyroptosis in the Progression and Targeted Therapeutic Approaches for Urological Malignancies.
Cheng W, Chen W, Jia R
J Inflamm Res. 2024; 17:9567-9581.
PMID: 39606639
PMC: 11600921.
DOI: 10.2147/JIR.S487740.
Cuproptosis, ferroptosis and PANoptosis in tumor immune microenvironment remodeling and immunotherapy: culprits or new hope.
Zhang X, Tang B, Luo J, Yang Y, Weng Q, Fang S
Mol Cancer. 2024; 23(1):255.
PMID: 39543600
PMC: 11566504.
DOI: 10.1186/s12943-024-02130-8.
Prognostic importance of the Scottish inflammatory prognostic score in patients with hepatocellular carcinoma after hepatectomy: a retrospective cohort study.
Shen S, Qiu X, Yang C, Li J, Peng Y, Wen Z
BMC Cancer. 2024; 24(1):1393.
PMID: 39533231
PMC: 11559137.
DOI: 10.1186/s12885-024-13174-w.
Integrated multiomics analysis identified comprehensive crosstalk between diverse programmed cell death patterns and novel molecular subtypes in Hepatocellular Carcinoma.
Chen L, Hu Y, Li Y, Zhang B, Wang J, Deng M
Sci Rep. 2024; 14(1):27529.
PMID: 39528670
PMC: 11555373.
DOI: 10.1038/s41598-024-78911-4.